Andrews, N.C. 1999. Disorders of iron metabolism. N Engl J Med 341:1986-1995.
Cook, J.D., Flowers, C.H., and Skikne, B.S. 2003. The quantitative assessment of body iron. Blood 9:9.
Faich G; Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans Am J Kidney Dis 1999 Mar;33(3):464-70
Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood. 2000 Aug 1;96(3):823-33.
Anemia of Chronic Disease
Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, and Eliopoulos GD, Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 2002.
Pettersson, T., Kivivuori, S.M., and Siimes, M.A. 1994. Is serum transferrin receptor useful for detecting iron-deficiency in anaemic patients with chronic inflammatory diseases? Br J Rheumatol 33:740-744
Rimon, E., Levy, S., Sapir, A., Gelzer, G., Peled, R., Ergas, D., and Sthoeger, Z.M. 2002. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med 162:445-449.
Skikne, B.S., Flowers, C.H., and Cook, J.D. 1990. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 75:1870-1876
Erythropoietin
Barosi, G. 1994. Inadequate erythropoietin response to anemia: definition and clinical relevance. Ann Hematol 68:215-223.
Cella, D., Zagari, M.J., Vandoros, C., Gagnon, D.D., Hurtz, H.J., and Nortier, J.W. 2003. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 21:366-373
Crawford, J., Cella, D., Cleeland, C.S., Cremieux, P.Y., Demetri, G.D., Sarokhan, B.J., Slavin, M.B., and Glaspy, J.A. 2002. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 95:888-895.
Miller, C.B., Jones, R.J., Piantadosi, S., Abeloff, M.D., and Spivak, J.L. 1990. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689-1692.
Seidenfeld, J., Piper, M., Flamm, C., Hasselblad, V., Armitage, J.O., Bennett, C.L., Gordon, M.S., Lichtin, A.E., Wade, J.L., 3rd, Woolf, S., et al. 2001. Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst93:1204-1214.
B12/Folate deficiency
Carmel, R, Karmaze DS, the deoxyuridine suppression test identifies sibtle cobalamin deficiencies in patients with typical megaloblastic anemia. JAMA 253: 1284, 198
Pruthi, R.K. and Tefferi A. Pernicious anemia revisited. Mayo Clin Proc 1994 Feb;69(2):144-50
Toh, BH, et al., Pernicious Anemia, NEJM, Vol 13: 337 (20), 1441-8